tiprankstipranks
Xeris Pharmaceuticals (XERS)
NASDAQ:XERS

Xeris Pharmaceuticals (XERS) Cash flow

881 Followers

Xeris Pharmaceuticals Cash Flow

XERS's free cash flow for Q3 2023 was $―. For the 2023 fiscal year, XERS's free cash flow was decreased by $-15.29M and operating cash flow was $―. See a summary of the company’s cash flow.
Cash Flow
TTM
Jun 23Mar 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -42.26M$ -39.88M$ -26.14M$ -102.89M$ -95.53M$ -80.56M
Investing Cash Flow
$ -34.81M$ -35.53M$ -43.98M$ 34.46M$ 97.96M$ -27.41M
Financing Cash Flow
$ 48.29M$ -307.00K$ -863.00K$ 127.47M$ 27.25M$ 126.06M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 181.65M$ 50.60M$ 55.33M$ 126.31M$ 67.27M$ 37.60M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 13.00M$ 15.21M$ 9.83M$ 10.86M$ 7.29M$ 4.55M
Issuance Of Capital Stock
-$ 549.00K-$ 30.00M$ 27.00M$ 65.89M
Issuance Of Debt
$ 48.92M--$ 146.21M$ 0.00$ 94.84M
Repayment Of Debt
---$ -43.50M$ 0.00$ -25.09M
Free Cash Flow
$ -42.63M$ -41.67M$ -26.38M$ -103.42M$ -96.62M$ -80.94M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Xeris Pharmaceuticals Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis